Evidence map›Paper›PMID 38178201›Full record

ArticleJournal of orthopaedic surgery and research2024

m

Dawei Zhang, Qingzhu Guo, Kemin You, Yi Zhang, Yao Zheng, Tao Wei

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of orthopaedic surgery and research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.4field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. The role of circRNAs in resistance to doxorubicin.Cell communication and signaling : CCS · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Dawei ZhangDepartment of Orthopedics, Zibo Central Hospital, Shandong First Medical University, Zibo, 255036, Shandong, China.
Qingzhu GuoDepartment of Emergency, Zibo Central Hospital, Shandong First Medical University, Zibo, 255036, Shandong, China.
Kemin YouDepartment of Orthopedics, Zibo Central Hospital, Shandong First Medical University, Zibo, 255036, Shandong, China.
Yi ZhangDepartment of Orthopedics, Zibo Central Hospital, Shandong First Medical University, Zibo, 255036, Shandong, China.
Yao ZhengDepartment of Pathology, Zibo Central Hospital, Shandong First Medical University, Zibo, 255036, Shandong, China.
Tao WeiDepartment of Orthopedics, Zibo Central Hospital, Shandong First Medical University, Zibo, 255036, Shandong, China. professor_weitao@yeah.net.
Central Hospital of Zibo · CNShandong First Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chemotherapy resistance accompanied by energy metabolism abnormality functions as one of the main reasons for treatment failure and poor prognosis. However, the function of N

Indexed as

Bone NeoplasmsOsteosarcomaDoxorubicinGlycolysisHumansRNA, CircularDoxorubicinRNA, CircularAerobic glycolysiscircARHGAP12c-MycDoxorubicinOsteosarcoma

Identifiers

PMID38178201
PMCPMC10768094
OpenAlexW4390578303

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.